论文信息 - Treatment of Systemic Lupus Erythematosus using BCMA-CD19 Compound CAR - 字舞流文

Treatment of Systemic Lupus Erythematosus using BCMA-CD19 Compound CAR

Lei Xu | Yupo Ma | Qingwen Wang | Lihua Sun | M. Wada | K. Pinz | Hongyu Zhang | Qi Chen | Jia Feng | Qian Zhang | Xun Jiang | Haichan Xu | Andrew Cinquina | Wenli Zhang

[1] Linrong Lu,et al. Therapeutic efficacy of anti-CD19 CAR-T cells in a mouse model of systemic lupus erythematosus , 2020, Cellular & Molecular Immunology.

[2] Yupo Ma,et al. First-in-Human Trial of Bcma-CD19 Compound CAR with Remarkable Donor-Specific Antibody Reduction. , 2019, Blood.

[3] M. Radic,et al. Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus , 2019, Science Translational Medicine.

[4] A. Radbruch,et al. Bortezomib Plus Continuous B Cell Depletion Results in Sustained Plasma Cell Depletion and Amelioration of Lupus Nephritis in NZB/W F1 Mice , 2015, PloS one.

[5] O. Rosen,et al. Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system. , 2009, Blood.

[6] Thomas F. Tedder,et al. Maintenance of Long-Lived Plasma Cells and Serological Memory Despite Mature and Memory B Cell Depletion during CD20 Immunotherapy in Mice1 , 2008, The Journal of Immunology.

[7] Bin Wang,et al. Effective treatment of autoimmune disease and progressive renal disease by mixed bone-marrow transplantation that establishes a stable mixed chimerism in BXSB recipient mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.